N,N-Dimethylglycine

HCID 673CAS 1118-68-9

Basic information

Standard SMILES
CN(C)CC(=O)O
InChIKey
FFDGPVCHZBVARC-UHFFFAOYSA-N
Molecular formula
C4H9NO2
Average molar mass
103.12 g/mol
Monoisotopic mass
103.06332853

Names & identifiers

Preferred name
N,N-Dimethylglycine
IUPAC
2-(dimethylamino)acetic acid
English name
N,N-Dimethylglycine
Molecular formula
C4H9NO2
Molecular weight
103.12

Names & synonyms

N,N-dimethylglycine1118-68-9dimethylglycine2-(dimethylamino)acetic acid(Dimethylamino)acetic acidN-Methylsarcosineglycine, N,N-dimethyl-N,N-Dimethylaminoacetic acid7797M4CPPADTXSID6074336CHEBI:177242-(dimethylazaniumyl)acetate
Show more names
N-Me-Sar-OHAKOS BB-5614N-DiMethylglycineN,N-DimthylglycineN. N-methylglycinen,n-dimethyl-glycin
RefChem:57349DTXCID1033244214-267-8N,N-Dimethyl GlycineMFCD00004283dimethyl glycineBRN 1700261DMG

Database identifiers

CAS
1118-68-9
PubChem CID
673
DTXSID
DTXSID6074336
ChEMBL
CHEMBL1232274
ChEBI
CHEBI:17724
UNII
7797M4CPPA
EC Number
214-267-8
Nikkaji
J135.420E

Properties

Computed structural properties

XLogP
-2.9
Topological polar surface area
40.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
2
Heavy atoms
7

Experimental & physicochemical properties

LogP · 2 items

-2.91

-2.91

Boiling Point63.9
Melting Point · 2 items

185.5

185.5 °C

Physical DescriptionSolid
Dissociation Constants2.04
Collision Cross Section · 3 items

119.7 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

116 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]

123.1 Ų [M+H]+

Physicochemical properties

Melting point
178 · 178-182 °C(lit.)
Boiling point
193.35 °C · 193.35°C (rough estimate)
Density
1 g/cm3 · 1 g/cm3
refractive index
1.4674 · 1.4674 (estimate)
storage temp.
Keep in dark place,Sealed in dry,Room Temperature
solubility
Methanol (Slightly), Water (Slightly)

Safety & regulation

GHS classification

GHS Classification · 6 items

This chemical does not meet GHS hazard criteria for 53.2% (58 of 109) of all reports.

Warning

H302 (46.8%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 109 reports by companies from 4 notifications to the ECHA C&L Inventory.;Reported as not meeting GHS hazard criteria per 58 of 109 reports by companies.;There are 3 notifications provided by 51 of 109 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

Hazard information

Regulatory Information · 3 items

PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.

Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/19838

Dimethylglycine: Non hazardous

Hazard Classes and CategoriesAcute Tox. 4 (46.8%)

Regulatory information

Regulatory Information · 3 items

PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.

Status: Active Update: 22-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/19838

Dimethylglycine: Non hazardous

Safety data

F
3
wgk
3
tsca
TSCA listed
rtecs
MB9865000
hs_code
29224999
Toxicity
rat,LD50,oral,> 650mg/kg (650mg/kg),BEHAVIORAL: ATAXIABLOOD: CHANGES IN SPLEENGASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA",Acute Toxicity Data. Journal of the American College of Toxicology, Part B. Vol. 1, Pg. 199, 1992.

Chemistry & industry

Pharmacology

Tissue LocationsKidney;Liver;Placenta
Cellular LocationsCytoplasm;Mitochondria
Metabolite Pathways · 1 item

3-Phosphoglycerate dehydrogenase deficiency;Cystathionine Beta-Synthase Deficiency;Dihydropyrimidine Dehydrogenase Deficiency (DHPD);Dimethylglycine Dehydrogenase Deficiency;Dimethylglycine Dehydrogenase Deficiency;Glycine N-methyltransferase Deficiency;Glycine, serine and threonine metabolism;Glycine, serine and threonine metabolism;Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type;Hyperglycinemia, non-ketotic;Total 18 pathways, visit the HMDB page for details

Uses & manufacturing

General Manufacturing InformationGlycine, N,N-dimethyl-: ACTIVE
Applications · 4 items

DescriptionN,N-Dimethylglycine (DMG) is a N-methylated product of the amino acid glycine. It is found in beans and liver. It can be formed from trimethylglycine upon the loss of one of its methyl groups. It is also a byproduct of the metabolism of choline. When DMG was first discovered, it was referred to as vitamin B16, but, unlike true B vitamins, deficiency of DMG in the diet does not lead to any ill-effects meaning it does not meet the definition of a vitamin. It is used in comparative analysis with other N-methylated glycines. N,N-Dimethylglycine is used in the development of glycine-based ionic liquids and emulsifiers, and as a substrate to identify, differentiate and characterize amino acid methyltransferase(s). It is potentially useful as a biomarker of protein degradation in COPD patients.

HistoryN,N-Dimethylglycine was discovered in 1943. It is found in some but not all formulations of pangamic acid (vitamin B15). Pangamic acid has been sold as a dietary supplement in the United States at least since the late 1970s, when the lay press celebrated its benefits. Although pangamic acid is also known as vitamin B16, it is not actually a vitamin because no deficiency state has been identified, and it has no known nutritional value.

UsesN,N-Dimethylglycine is used as an athletic performance enhancer and immunostimulant. It is also used in the treatment of autism, epilepsy and mitochondrial disease. It is also employed as a biomarker of protein degradation in chronic obstructive lung disease (COPD) patients. Further, it is used as a substrate to identify, differentiate and characterize amino acid methyltransferase. It plays an important role for the development of glycine-based ionic liquids and emulsifiers.

General DescriptionN,N-Dimethylglycine is a type of quaternary ammonium compound which exhibits a variety of biological effects.

Preparation methods · 1 item

PreparationN,N-Dimethylglycine is commercially available as the free form amino acid, and as the hydrochloride salt [2491-06-7 ]. DMG may be prepared by the alkylation of glycine via the Eschweiler–Clarke reaction. In this reaction, glycine is treated with aqueous formaldehyde in formic acid that serves as both solvent and reductant. Hydrochloric acid is added thereafter to give the hydrochloride salt. The free amino acid may been obtained by neutralization of the acid salt, which has been performed with silver oxide. H2NCH2COOH + 2 CH2O + 2 HCOOH →(CH3)2NCH2COOH + 2 CO2 + 2 H2O.

Suppliers50 total

国药集团化学试剂有限公司86-21-63210123 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
衢州润东化工有限公司0570-8789886 18892685668 · [email protected]
爱斯特(成都)生物制药股份有限公司+86-28-85122536 85324413 · [email protected]
山东前元高分子材料有限公司18678041314 18765609661 · [email protected]
Additional notes · 1 item

DefinitionChEBI: N,N-dimethylglycine is an N-methylglycine that is glycine carrying two N-methyl substituents. It has a role as a human metabolite, a Daphnia magna metabolite and a mouse metabolite. It is a N-methyl-amino acid and a member of N-methylglycines. It is a tautomer of a N,N-dimethylglycine zwitterion.

Related reactions

1,037 records

Linked notes

Loading…